ReviewCurrent neurology and neuroscience reports2010
Biomarkers in Parkinson's disease.
Review in Current neurology and neuroscience reports, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- Integrated bioinformatics analysis unravels mitochondrial-immune crosstalk and infiltration dynamics in sepsis progression.European journal of medical research · 2025Article
- Can Corticomuscular Coherence Differentiate between REM Sleep Behavior Disorder with or without Parkinsonism?Journal of clinical medicine · 2021Article
- Advances in Biomarker Research in Parkinson's Disease.Current neurology and neuroscience reports · 2016Review
- Proteomic profiling in MPTP monkey model for early Parkinson disease biomarker discovery.Biochimica et biophysica acta · 2015Article
- α-Synuclein inclusions in the skin of Parkinson's disease and parkinsonism.Annals of clinical and translational neurology · 2014Article
- Instrumented functional reach test differentiates individuals at high risk for Parkinson's disease from controls.Frontiers in aging neuroscience · 2014Article
- Rodent models and contemporary molecular techniques: notable feats yet incomplete explanations of Parkinson's disease pathogenesis.Molecular neurobiology · 2012Review
- Premotor biomarkers for Parkinson's disease - a promising direction of research.Translational neurodegeneration · 2012Article
- Discovery and verification of panels of T-lymphocyte proteins as biomarkers of Parkinson's disease.Scientific reports · 2012Article
- Biomarker candidates of neurodegeneration in Parkinson's disease for the evaluation of disease-modifying therapeutics.Journal of neural transmission (Vienna, Austria : 1996) · 2012Review
- Analysis of EMG and acceleration signals for quantifying the effects of deep brain stimulation in Parkinson's disease.IEEE transactions on bio-medical engineering · 2011Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Biomarkers are objectively measured characteristics that are indicators of normal biological processes, pathogenic processes, or responses to therapeutic interventions. To date, clinical assessment remains the gold standard in the diagnosis of Parkinson's disease (PD) and clinical rating scales are well established as the gold standard for tracking progression of PD. Researchers have identified numerous potential biomarkers that may aid in the differential diagnosis of PD and/or tracking disease progression. Clinical, genetic, blood and cerebrospinal fluid (proteomics, transcriptomics, metabolomics), and neuroimaging biomarkers may provide useful tools in the diagnosis of PD and in measuring disease progression and response to therapies. Some potential biomarkers are inexpensive and do not require much technical expertise, whereas others are expensive or require specialized equipment and technical skills. Many potential biomarkers in PD show great promise; however, they need to be assessed for their sensitivity and specificity over time in large and varied samples of patients with and without PD.
Indexed as
Identifiers
20809400What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.